Somatostatin-Dopamine Chimeric Molecules in Neuroendocrine Neoplasms
Neuroendocrine neoplasms (NENs) are a widely heterogeneous family of neoplasms arising from neuroendocrine cells, which are interspersed throughout the body. Despite NENs are relatively rare, their incidence and prevalence are constantly increasing probably due to the improvement in earlier diagnosi...
Main Authors: | Maria Celeste Cantone, Alessandra Dicitore, Giovanni Vitale |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/3/501 |
Similar Items
-
Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms
by: Maria Isabel del Olmo-Garcia, et al.
Published: (2021-12-01) -
Role of Somatostatin Signalling in Neuroendocrine Tumours
by: Olesja Rogoza, et al.
Published: (2022-01-01) -
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
by: Giuseppe Fanciulli, et al.
Published: (2022-08-01) -
Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
by: Yuheng Hu, et al.
Published: (2021-05-01) -
Radiolabeled Somatostatin Analogs—A Continuously Evolving Class of Radiopharmaceuticals
by: Melpomeni Fani, et al.
Published: (2022-02-01)